Vaccine Stocks: Trading Moderna, Pfizer and Novavax Amid Omicron Outbreak

— Vaccine stocks are in the spotlight as the Omicron Covid variant runs around the world. Let's look at how the charts are setting up now. — By Bret Kenwell, TheStreet.com Vaccines have been in heavy demand due to the ongoing Covid-19 pandemic. As a result, the major vaccine stocks have been in the spotlight. They are largely identified as...

Monday’s Meltdown Makes Tuesday a Critical Day

Fears of more trouble from omicron ended up getting the better of investors on Monday, despite Friday's late rebound effort. All told, stocks closed about 1.2% lower to get the new trading week going. We've survived worse, of course. In fact, we've come roaring back from worse. As the often-dangerous saying goes though, this time could be different. In question...

Monday’s Meltdown Makes Tuesday a Critical Day

Fears of more trouble from omicron ended up getting the better of investors on Monday, despite Friday's late rebound effort. All told, stocks closed about 1.2% lower to get the new trading week going. We've survived worse, of course. In fact, we've come roaring back from worse. As the often-dangerous saying goes though, this time could be different. In question...

Weekly Market Outlook – The Battle Lines Have Been Drawn, and Verified

The bulls tried to put a second consecutive weekly win in the books, but it just wasn't meant to be. In fact, the modest bullish bounce that started to take shape on Friday faded just a bit before the closing bell rang. That lull wasn't a devastating blow, but some of the indices are once again testing key support lines....

Weekly Market Outlook – The Battle Lines Have Been Drawn, and Verified

The bulls tried to put a second consecutive weekly win in the books, but it just wasn't meant to be. In fact, the modest bullish bounce that started to take shape on Friday faded just a bit before the closing bell rang. That lull wasn't a devastating blow, but some of the indices are once again testing key support lines....

One of the Nasdaq 100’s latest stock inductees should continue its outperformance, traders say

By Keris Lahiff, CNBC The Nasdaq 100 is welcoming a few new additions to its exclusive club. Next Monday, the tech-heavy index will add Palo Alto Networks, Airbnb, Fortinet, Lucid Group, Zscaler and Datadog and subtract CDW, Fox, Cerner, Check Point Software, Trip.com and Incyte. Those latest inductees received the Nasdaq's seal of approval, but what about investors? CNBC's "Trading...

Is Dogecoin a Buy After Tesla’s Elon Musk Tweets About It?

— Dogecoin prices are erupting higher on Tuesday following a tweet from Tesla CEO Elon Musk. Here's how to trade the cryptocurrency now. — By Bret Kenwell, TheStreet.com Dogecoin is erupting higher on the day, up more than 20% so far on Tuesday. However, bulls are likely somewhat discouraged with the price action, despite the lofty gains. That's as dogecoin...

Weekly Market Outlook – Last Week Wasn’t Quite as Bullish as the Numbers Suggest

When all was said and done last week, the S&P 500 had gained 3.8% from the previous Friday's close, logging a record-high close in the process. The move also stopped — and then reversed — some pretty strong selling suffered over the course of the prior two weeks. Not bad. It looks like traders are anticipating a Santa Claus rally...
BECOME A BIG TRENDS INSIDER! IT’S FREE!